BRIEF published on 10/23/2025 at 16:08, 1 year ago The Vanguard Group Discloses Position in JTC plc Form 8.3 The Vanguard Group Takeover Code Securities Disclosure JTC Plc
BRIEF published on 10/23/2025 at 16:07, 1 year ago The Vanguard Group Discloses Interests in Avadel Pharmaceuticals Form 8.3 Securities Disclosure Vanguard Group Irish Takeover Avadel Pharmaceuticals
PRESS RELEASE published on 10/23/2025 at 16:06, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.58% stake in Qualcomm Incorporated as per Form 8.3 filing with the Takeover Code on 22 Oct 2025 Form 8.3 Takeover Code Vanguard Group Stake Disclosure Qualcomm Incorporated
BRIEF published on 10/23/2025 at 16:05, 1 year ago The Vanguard Group Discloses Position in Mural Oncology plc Securities Form 8.3 Disclosure Vanguard Group Mural Oncology
PRESS RELEASE published on 10/23/2025 at 16:04, 1 year ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group discloses a 7.52% stake in American Axle & Manufacturing Holdings, Inc. through stock holdings as of 22 Oct 2025 Vanguard Group Financial Disclosure Stake Disclosure Stock Holdings American Axle
BRIEF published on 10/23/2025 at 16:04, 1 year ago The Vanguard Group Discloses Position in Greencore Group plc Takeover Code Vanguard Group Shareholding Bakkavor Group Greencore Group
PRESS RELEASE published on 10/23/2025 at 16:03, 1 year ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 5.04% stake in JTC plc through relevant securities. Form 8.3 filed under the Takeover Code Form 8.3 The Vanguard Group Takeover Code Stake Disclosure JTC Plc
BRIEF published on 10/23/2025 at 16:03, 1 year ago The Vanguard Group Discloses Position in Spire Healthcare Form 8.3 Takeover Code Securities Disclosure Vanguard Group Spire Healthcare
PRESS RELEASE published on 10/23/2025 at 16:02, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.67% stake in Avadel Pharmaceuticals plc. Details under Rule 8.3 of the Irish Takeover Panel Act, 1997 Irish Takeover Panel The Vanguard Group Rule 8.3 Stake Disclosure Avadel Pharmaceuticals Plc
BRIEF published on 10/23/2025 at 16:02, 1 year ago The Vanguard Group Discloses Alphawave IP Stake Takeover Code Vanguard Group Securities Stake Qualcomm Alphawave IP
Published on 11/10/2026 at 21:00, 18 minutes ago Golden Minerals Announces Completion of Offering for C$5,000,000
Published on 11/10/2026 at 14:45, 6 hours 33 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 6 hours 47 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 6 hours 48 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 6 hours 48 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 18:54, 2 hours 23 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 2 hours 33 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:30, 2 hours 48 minutes ago Shelly Group Accelerates Revenue Growth in the Third Quarter and Confirms Full-Year 2026 Guidance
Published on 11/10/2026 at 18:20, 2 hours 58 minutes ago Edison issues report on Custodian Property Income REIT (LSE: CREI)
Published on 11/10/2026 at 17:31, 3 hours 46 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 7 hours 18 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 10 hours 15 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 14 hours 18 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 2 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
